News
Antibiotics backed as standard of care for myomectomies
Women in the no-antibiotic group were 4.59 times more likely to have a surgical site infection.
News
CHMP backs blinatumomab for MRD
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding marketing authorization for...
News
Jornay PM improves classroom functioning in ADHD
A phase 3 laboratory classroom study confirms the functional benefits of Jornay PM, a novel formulation of methylphenidate.
News
Consider omitting CSF testing in older, low-risk febrile infants
To confirm the safety of omitting CSF testing in low-risk febrile infants older than 28 days, a prospective study will be needed.
News
Two-stage preeclampsia screening cuts cost, preserves effectiveness
The results support the effectiveness of using only certain tests paired with maternal factors to identify high-risk patients for further...
News
Adjunctive Promacta approved for first-line SAA
Among the patients treated at the recommended dosing schedule, the 6-month overall response rate was 79%, and the complete response rate was 44...
News
Eltrombopag approved as first-line SAA therapy
The U.S.